AI-Driven Drug Safety

How AI Automates Drug Safety Reporting to Government Health Agencies: A Product Manager’s Approach to Innovation

Table of Contents

  1. Summary
  2. Case Study
  3. About Amit Arora


Tracking and reporting adverse drug reactions is serious business for pharmaceutical companies, requiring them to process large and diverse streams of data from multiple sources to detect incidents. Strict reporting requirements and timelines from the FDA and other mandates impose sharp fiscal penalties for delayed response. This GigaOm Business and Technology Impact report describes how one company applied automation and AI to enhance detection, reduce response times, and improve patient outcomes.

Full content available to GigaOm Subscribers.

Sign Up For Free